ABILIFY INJ. Products Affected Step 2: ABILIFY MAINTENA PREFILLED SYRINGE 300 MG INTRAMUSCULAR ABILIFY MAINTENA PREFILLED SYRINGE 400 MG INTRAMUSCULAR

Size: px
Start display at page:

Download "ABILIFY INJ. Products Affected Step 2: ABILIFY MAINTENA PREFILLED SYRINGE 300 MG INTRAMUSCULAR ABILIFY MAINTENA PREFILLED SYRINGE 400 MG INTRAMUSCULAR"

Transcription

1 ABILIFY INJ ABILIFY MAINTENA PREFILLED SYRINGE 300 MG ABILIFY MAINTENA PREFILLED SYRINGE 400 MG ABILIFY MAINTENA SUSPENSION RECONSTITUTED ER 300 MG Claim will pay automatically for ABILIFY MAINTENA if enrollee has a paid claim for at least a 1 days supply of a Latuda AND aripiprazole in the past 365 days. Otherwise, require a step therapy exception request indicating any ONE of the following: (1) History of inadequate treatment response with Latuda or aripiprazole, OR (2) history of adverse event with Latuda, OR (3)Latuda is contraindicated. 1

2 ANTICONVULSANTS APTIOM TABLET 200 MG APTIOM TABLET 400 MG APTIOM TABLET 600 MG APTIOM TABLET 800 MG BANZEL SUSPENSION 40 MG/ML BANZEL TABLET 200 MG BANZEL TABLET 400 MG BRIVIACT SOLUTION 10 MG/ML BRIVIACT TABLET 10 MG BRIVIACT TABLET 100 MG BRIVIACT TABLET 25 MG BRIVIACT TABLET 50 MG BRIVIACT TABLET 75 MG CELONTIN CAPSULE 300 MG FYCOMPA SUSPENSION 0.5 MG/ML FYCOMPA TABLET 10 MG FYCOMPA TABLET 12 MG FYCOMPA TABLET 2 MG FYCOMPA TABLET 4 MG FYCOMPA TABLET 6 MG FYCOMPA TABLET 8 MG ONFI SUSPENSION 2.5 MG/ML ONFI TABLET 10 MG ONFI TABLET 20 MG PEGANONE TABLET 250 MG SPRITAM TABLET DISINTEGRATING SOLUBLE 1000 MG SPRITAM TABLET DISINTEGRATING SOLUBLE 250 MG SPRITAM TABLET DISINTEGRATING SOLUBLE 500 MG SPRITAM TABLET DISINTEGRATING SOLUBLE 750 MG VIMPAT SOLUTION 10 MG/ML VIMPAT SOLUTION 200 MG/20ML INTRAVENOUS VIMPAT TABLET 150 MG VIMPAT TABLET 200 MG VIMPAT TABLET 50 MG Claim will pay automatically for Brand Anticonvulsants if enrollee has a paid claim for at least a 1 days supply of a Generic Anticonvulsant in the past 365 days. Otherwise, Brand Anticonvulsants require a step therapy exception request indicating: (1) history of inadequate treatment response with Generic Anticonvulsants, OR (2) history of adverse event with Generic Anticonvulsants, OR (3)Generic Anticonvulsants is contraindicated. 2

3 ANTIDEPRESSANTS amoxapine tablet 100 mg oral amoxapine tablet 150 mg oral amoxapine tablet 25 mg oral amoxapine tablet 50 mg oral citalopram hydrobromide solution 10 mg/5ml oral citalopram hydrobromide tablet 10 mg oral citalopram hydrobromide tablet 20 mg oral citalopram hydrobromide tablet 40 mg oral EMSAM PATCH 24 HOUR 12 MG/24HR TRANSDERMAL EMSAM PATCH 24 HOUR 6 MG/24HR TRANSDERMAL EMSAM PATCH 24 HOUR 9 MG/24HR TRANSDERMAL MARPLAN TABLET 10 MG TRINTELLIX TABLET 10 MG TRINTELLIX TABLET 20 MG TRINTELLIX TABLET 5 MG VIIBRYD STARTER PACK KIT 10 & 20 MG VIIBRYD TABLET 10 MG VIIBRYD TABLET 20 MG VIIBRYD TABLET 40 MG Claim will pay automatically for MARPLAN, EMSAM, AMOXAPINE, VIIBRYD, CITALOPRAM, OR TRINTELLIX if enrollee has a paid claim for at least a 1 days supply of MIRTAZAPINE, PHENELZINE SULFATE, TRANYLCYPROMINE SULFATE, NEFAZODONE HCL, TRAZODONE HCL, ESCITALOPRAM OXALATE, FLUOXETINE HCL, FLUVOXAMINE MALEATE, PAROXETINE HCL, PAXIL SUS, SERTRALINE HCL, DESVENLAFAXINE ER, DULOXETINE HCL, FETZIMA, FETZIMA TITRATION PACK, VENLAFAXINE HCL, VENLAFAXINE HCL ER, AMITRIPTYLINE HCL, DESIPRAMINE HCL, DOXEPIN HCL, IMIPRAMINE HCL, PROTRIPTYLINE HCL, MAPROTILINE HCL, BUPROPION HCL, BUPROPION HCL SR, or BUPROPION HCL XL in the past 365 days. Otherwise, MARPLAN, EMSAM, AMOXAPINE, VIIBRYD, CITALOPRAM OR TRINTELLIX require a step therapy exception request indicating: (1) history of inadequate treatment response with Step 1 Antidepressant, OR (2) history of adverse event with Step 1 Antidepressant, OR (3)Step 1 Antidepressant is contraindicated. 3

4 ATELVIA ATELVIA TABLET DELAYED RELEASE 35 MG Claim will pay automatically for Atelvia if enrollee has a paid claim for at least a 1 days supply of Alendronate, Ibandronate or Risedroante in the past 365 days. Otherwise, Atelvia requires a step therapy exception request indicating: (1) history of inadequate treatment response with Alendronate, Ibandronate or Risedroante, OR (2) history of adverse event with Alendronate, Ibandronate or Risedroante, OR (3) Alendronate, Ibandronate or Risedroante is contraindicated. 4

5 ATYPICALS ABILIFY MAINTENA PREFILLED SYRINGE 300 MG ABILIFY MAINTENA PREFILLED SYRINGE 400 MG ABILIFY MAINTENA SUSPENSION RECONSTITUTED ER 300 MG clozapine tablet 100 mg oral clozapine tablet 200 mg oral clozapine tablet dispersible 100 mg oral clozapine tablet dispersible 12.5 mg oral clozapine tablet dispersible 150 mg oral clozapine tablet dispersible 200 mg oral clozapine tablet dispersible 25 mg oral FANAPT TABLET 1 MG FANAPT TABLET 10 MG FANAPT TABLET 12 MG FANAPT TABLET 2 MG FANAPT TABLET 4 MG FANAPT TABLET 6 MG FANAPT TABLET 8 MG FANAPT TITRATION PACK TABLET 1 & 2 & 4 & 6 MG FAZACLO TABLET DISPERSIBLE 100 MG FAZACLO TABLET DISPERSIBLE 12.5 MG FAZACLO TABLET DISPERSIBLE 150 MG FAZACLO TABLET DISPERSIBLE 200 MG FAZACLO TABLET DISPERSIBLE 25 MG GEODON SOLUTION RECONSTITUTED 20 MG INVEGA SUSTENNA SUSPENSION 117 MG/0.75ML 5 INVEGA SUSTENNA SUSPENSION 156 MG/ML INVEGA SUSTENNA SUSPENSION 234 MG/1.5ML INVEGA SUSTENNA SUSPENSION 39 MG/0.25ML INVEGA SUSTENNA SUSPENSION 78 MG/0.5ML INVEGA TRINZA SUSPENSION 273 MG/0.875ML INVEGA TRINZA SUSPENSION 410 MG/1.315ML INVEGA TRINZA SUSPENSION 546 MG/1.75ML INVEGA TRINZA SUSPENSION 819 MG/2.625ML NUPLAZID TABLET 17 MG RISPERDAL CONSTA SUSPENSION RECONSTITUTED 12.5 MG RISPERDAL CONSTA SUSPENSION RECONSTITUTED 25 MG RISPERDAL CONSTA SUSPENSION RECONSTITUTED 37.5 MG RISPERDAL CONSTA SUSPENSION RECONSTITUTED 50 MG SAPHRIS TABLET SUBLINGUAL 10 MG SUBLINGUAL SAPHRIS TABLET SUBLINGUAL 2.5 MG SUBLINGUAL SAPHRIS TABLET SUBLINGUAL 5 MG SUBLINGUAL VERSACLOZ SUSPENSION 50 MG/ML VRAYLAR CAPSULE 1.5 MG VRAYLAR CAPSULE 3 MG

6 VRAYLAR CAPSULE 4.5 MG VRAYLAR CAPSULE 6 MG VRAYLAR CAPSULE THERAPY PACK 1.5 & 3 MG ZYPREXA RELPREVV SUSPENSION RECONSTITUTED 210 MG Claim will pay automatically for ABILIFY MAINTENNA, CLOZAPINE TABLET (NON-ODT), INVEGA (SUSTENNA/TRINZA), NUPLAZID, ZYPREXA RELPREVV, FANAPT, FANAPT TITRATION PACK, RISPERDAL CONSTA, VERSACLOZ, CLOZAPINE ODT, FAZACLO, SAPHRIS, NUPLAZID, GEODON,VRAYLAR if enrollee has a paid claim for at least a 1 days supply of a Latuda OR 2 GENERIC AGENTS( ARIPIPRAZOLE, CHLORPROMAZINE, COMPRO, FLUPHENAZINE, HALOPERIDOL, LOXAPINE, OLANZAPINE, PALIPERIDONE, PERPHENAZINE, PROCHLORPERAZINE, QUETIAPINE, RISPERDONE, THIORIDAZINE, THIOTHIXENE, TRIFLUOPERAZINE, or ZIPRASIDONE) in the past 365 days. Otherwise, Non-Preferred Antipsychotics require a step therapy exception request indicating any ONE of the following (1) diagnosis that is not covered by Latuda (i.e. Acute treatment of agitation for Geodon injection), OR (2)history of inadequate treatment response with Latuda, OR (3) history of adverse event with Latuda, OR (4)Latuda is contraindicated (5) diagnosis that is not covered by Nuplazid (i.e. Parkinson's disease psychosis) 6

7 CAPS ILARIS (150MG DELIVERED) SOLUTION RECONSTITUTED 180 MG SUBCUTANEOUS Claim will pay automatically for Ilaris if enrollee has a paid claim for at least a 1 days supply of Arcalyst in the past 365 days. Otherwise, Ilaris requires a step therapy exception request indicating: (1) diagnosis not covered by Arcalyst such as systemic juvenile idiopathic arthritis (2) history of inadequate treatment response with Arcalyst, OR (3) history of adverse event with Arcalyst OR (4) Arcalyst is contraindicated. 7

8 CNS STIMULANTS atomoxetine hcl capsule 10 mg oral atomoxetine hcl capsule 100 mg oral atomoxetine hcl capsule 18 mg oral atomoxetine hcl capsule 25 mg oral atomoxetine hcl capsule 40 mg oral atomoxetine hcl capsule 60 mg oral atomoxetine hcl capsule 80 mg oral Claim will pay automatically for ATOMOXETINE if enrollee has paid claims history for any one of the following formulary CNS stimulants: amphetamine salts, dexmethylphenidate, dextroamphetamine, methylphenidate OR guanfacine ER. Otherwise, ATOMOXETINE requires a step therapy exception request indicating: (1) history of inadequate treatment response with amphetamine salts, dexmethylphenidate, dextroamphetaminemethylphenidate, OR guanfacine ER OR (2) history of adverse event with amphetamine salts, dexmethylphenidate, dextroamphetamine, methylphenidate, OR guanfacine ER OR (3)amphetamine salts, dexmethylphenidate, dextroamphetamine, methylphenidate OR guanfacine ER is contraindicated. 8

9 ELIDEL ELIDEL CREAM 1 % EXTERNAL Claim will pay automatically for Elidel if enrollee has paid claims history for at least 2 different formulary topical steroids. 9

10 FENTANYL fentanyl patch 72 hour 100 mcg/hr fentanyl patch 72 hour 12 mcg/hr fentanyl patch 72 hour 25 mcg/hr fentanyl patch 72 hour 37.5 mcg/hr fentanyl patch 72 hour 50 mcg/hr fentanyl patch 72 hour 62.5 mcg/hr fentanyl patch 72 hour 75 mcg/hr fentanyl patch 72 hour 87.5 mcg/hr Claim will pay automatically for Fentanyl patches if enrollee has paid claims history of any 1 days supply in the past 365 days of Morphine ER, Methadone, morphine oral solution OR buprenorphine patches. Otherwise, the drug requires a step therapy exception request indicating any ONE of the following: (1) history of inadequate treatment response with Morphine ER, Methadone, morphine oral solution OR buprenorphine patches, OR (2) history of adverse event with Morphine ER, Methadone, morphine oral solution OR buprenorphine patches, OR (3) Morphine ER, Methadone, morphine oral solution OR buprenorphine patches are contraindicated. 10

11 RANEXA RANEXA TABLET EXTENDED RELEASE 12 HOUR 1000 MG RANEXA TABLET EXTENDED RELEASE 12 HOUR 500 MG Claim will pay automatically for RANEXA if enrollee has a paid claim for at least a 1 day supply of AMLODIPINE, ATENOLOL, DILTIAZEM, ISOSORBIDE DINITRATE, ISOSORBIDE MONONITRATE, METOPROLOL, NADOLOL, NICARDIPINE, NITROGLYCERIN, PROPRANOLOL in the past 365 days. Otherwise RANEXA requires a step therapy exception request indication any ONE of the following: (1) history of inadequate treatment response with step 1 agents or (2) history of adverse event with a step 1 agent or (3) step 1 agents are contraindicated. 11

12 ULORIC ULORIC TABLET 40 MG ULORIC TABLET 80 MG Claim will pay automatically for Uloric if enrollee has a paid claim for at least a 1 days supply of Allopurinol in the past 365 days. Otherwise, Uloric requires a step therapy exception request indicating: (1) history of inadequate treatment response with Allopurinol, OR (2) history of adverse event with Allopurinol, OR (3) Allopurinol is contraindicated. 12

13 Alphabetical Listing A ABILIFY MAINTENA PREFILLED SYRINGE 300 MG... 1, 5 ABILIFY MAINTENA PREFILLED SYRINGE 400 MG... 1, 5 ABILIFY MAINTENA SUSPENSION RECONSTITUTED ER 300 MG... 1, 5 amoxapine tablet 100 mg oral... 3 amoxapine tablet 150 mg oral... 3 amoxapine tablet 25 mg oral... 3 amoxapine tablet 50 mg oral... 3 APTIOM TABLET 200 MG... 2 APTIOM TABLET 400 MG... 2 APTIOM TABLET 600 MG... 2 APTIOM TABLET 800 MG... 2 ATELVIA TABLET DELAYED RELEASE 35 MG... 4 atomoxetine hcl capsule 10 mg oral... 8 atomoxetine hcl capsule 100 mg oral... 8 atomoxetine hcl capsule 18 mg oral... 8 atomoxetine hcl capsule 25 mg oral... 8 atomoxetine hcl capsule 40 mg oral... 8 atomoxetine hcl capsule 60 mg oral... 8 atomoxetine hcl capsule 80 mg oral... 8 B BANZEL SUSPENSION 40 MG/ML... 2 BANZEL TABLET 200 MG... 2 BANZEL TABLET 400 MG... 2 BRIVIACT SOLUTION 10 MG/ML... 2 BRIVIACT TABLET 10 MG... 2 BRIVIACT TABLET 100 MG... 2 BRIVIACT TABLET 25 MG... 2 BRIVIACT TABLET 50 MG... 2 BRIVIACT TABLET 75 MG... 2 C CELONTIN CAPSULE 300 MG... 2 citalopram hydrobromide solution 10 mg/5ml oral citalopram hydrobromide tablet 10 mg oral 3 citalopram hydrobromide tablet 20 mg oral 3 citalopram hydrobromide tablet 40 mg oral 3 clozapine tablet 100 mg oral... 5 clozapine tablet 200 mg oral... 5 clozapine tablet dispersible 100 mg oral... 5 clozapine tablet dispersible 12.5 mg oral... 5 clozapine tablet dispersible 150 mg oral... 5 clozapine tablet dispersible 200 mg oral... 5 clozapine tablet dispersible 25 mg oral... 5 E ELIDEL CREAM 1 % EXTERNAL... 9 EMSAM PATCH 24 HOUR 12 MG/24HR TRANSDERMAL... 3 EMSAM PATCH 24 HOUR 6 MG/24HR TRANSDERMAL... 3 EMSAM PATCH 24 HOUR 9 MG/24HR TRANSDERMAL... 3 F FANAPT TABLET 1 MG... 5 FANAPT TABLET 10 MG... 5 FANAPT TABLET 12 MG... 5 FANAPT TABLET 2 MG... 5 FANAPT TABLET 4 MG... 5 FANAPT TABLET 6 MG... 5 FANAPT TABLET 8 MG... 5 FANAPT TITRATION PACK TABLET 1 & 2 & 4 & 6 MG... 5 FAZACLO TABLET DISPERSIBLE 100 MG... 5 FAZACLO TABLET DISPERSIBLE 12.5 MG... 5 FAZACLO TABLET DISPERSIBLE 150 MG... 5 FAZACLO TABLET DISPERSIBLE 200 MG... 5 FAZACLO TABLET DISPERSIBLE 25 MG... 5 fentanyl patch 72 hour 100 mcg/hr fentanyl patch 72 hour 12 mcg/hr... 10

14 fentanyl patch 72 hour 25 mcg/hr fentanyl patch 72 hour 37.5 mcg/hr fentanyl patch 72 hour 50 mcg/hr fentanyl patch 72 hour 62.5 mcg/hr fentanyl patch 72 hour 75 mcg/hr fentanyl patch 72 hour 87.5 mcg/hr FYCOMPA SUSPENSION 0.5 MG/ML... 2 FYCOMPA TABLET 10 MG... 2 FYCOMPA TABLET 12 MG... 2 FYCOMPA TABLET 2 MG... 2 FYCOMPA TABLET 4 MG... 2 FYCOMPA TABLET 6 MG... 2 FYCOMPA TABLET 8 MG... 2 G GEODON SOLUTION RECONSTITUTED 20 MG... 5 I ILARIS (150MG DELIVERED) SOLUTION RECONSTITUTED 180 MG SUBCUTANEOUS... 7 INVEGA SUSTENNA SUSPENSION 117 MG/0.75ML... 5 INVEGA SUSTENNA SUSPENSION 156 MG/ML... 5 INVEGA SUSTENNA SUSPENSION 234 MG/1.5ML... 5 INVEGA SUSTENNA SUSPENSION 39 MG/0.25ML... 5 INVEGA SUSTENNA SUSPENSION 78 MG/0.5ML... 5 INVEGA TRINZA SUSPENSION 273 MG/0.875ML... 5 INVEGA TRINZA SUSPENSION 410 MG/1.315ML... 5 INVEGA TRINZA SUSPENSION 546 MG/1.75ML... 5 INVEGA TRINZA SUSPENSION 819 MG/2.625ML M MARPLAN TABLET 10 MG... 3 N NUPLAZID TABLET 17 MG... 5 O ONFI SUSPENSION 2.5 MG/ML.. 2 ONFI TABLET 10 MG... 2 ONFI TABLET 20 MG... 2 P PEGANONE TABLET 250 MG... 2 R RANEXA TABLET EXTENDED RELEASE 12 HOUR 1000 MG 11 RANEXA TABLET EXTENDED RELEASE 12 HOUR 500 MG. 11 RISPERDAL CONSTA SUSPENSION RECONSTITUTED 12.5 MG... 5 RISPERDAL CONSTA SUSPENSION RECONSTITUTED 25 MG... 5 RISPERDAL CONSTA SUSPENSION RECONSTITUTED 37.5 MG... 5 RISPERDAL CONSTA SUSPENSION RECONSTITUTED 50 MG... 5 S SAPHRIS TABLET SUBLINGUAL 10 MG SUBLINGUAL... 5 SAPHRIS TABLET SUBLINGUAL 2.5 MG SUBLINGUAL... 5 SAPHRIS TABLET SUBLINGUAL 5 MG SUBLINGUAL... 5 SPRITAM TABLET DISINTEGRATING SOLUBLE 1000 MG... 2 SPRITAM TABLET DISINTEGRATING SOLUBLE 250 MG... 2 SPRITAM TABLET DISINTEGRATING SOLUBLE 500 MG... 2 SPRITAM TABLET DISINTEGRATING SOLUBLE 750 MG... 2 T TRINTELLIX TABLET 10 MG... 3 TRINTELLIX TABLET 20 MG... 3

15 TRINTELLIX TABLET 5 MG... 3 U ULORIC TABLET 40 MG ULORIC TABLET 80 MG V VERSACLOZ SUSPENSION 50 MG/ML... 5 VIIBRYD STARTER PACK KIT 10 & 20 MG... 3 VIIBRYD TABLET 10 MG... 3 VIIBRYD TABLET 20 MG... 3 VIIBRYD TABLET 40 MG... 3 VIMPAT SOLUTION 10 MG/ML. 2 VIMPAT SOLUTION 200 MG/20ML INTRAVENOUS... 2 VIMPAT TABLET 150 MG... 2 VIMPAT TABLET 200 MG... 2 VIMPAT TABLET 50 MG... 2 VRAYLAR CAPSULE 1.5 MG... 5 VRAYLAR CAPSULE 3 MG... 5 VRAYLAR CAPSULE 4.5 MG... 6 VRAYLAR CAPSULE 6 MG... 6 VRAYLAR CAPSULE THERAPY PACK 1.5 & 3 MG... 6 Z ZYPREXA RELPREVV SUSPENSION RECONSTITUTED 210 MG

**CRITERIA UNDER CMS REVIEW**

**CRITERIA UNDER CMS REVIEW** **CRITERIA UNDER CMS REVIEW** ANTICONVULSANTS APTIOM TABLET 200 MG APTIOM TABLET 400 MG APTIOM TABLET 600 MG APTIOM TABLET 800 MG BANZEL SUSPENSION 40 MG/ML BANZEL TABLET 200 MG BANZEL TABLET 400 MG BRIVIACT

More information

ANTICONVULSANTS. Details. Step Therapy Criteria Date Effective: April 1, 2019

ANTICONVULSANTS. Details. Step Therapy Criteria Date Effective: April 1, 2019 Step Therapy Date Effective: April 1, 2019 ANTICONVULSANTS APTIOM TABLET 200 MG ORAL APTIOM TABLET 400 MG ORAL APTIOM TABLET 600 MG ORAL APTIOM TABLET 800 MG ORAL BANZEL SUSPENSION 40 MG/ML ORAL BANZEL

More information

ANTIDEPRESSANTS. Details. Step Therapy 2018 Last Updated: 8/21/2018

ANTIDEPRESSANTS. Details. Step Therapy 2018 Last Updated: 8/21/2018 ANTIDEPRESSANTS EMSAM PATCH 24 HOUR 12 MG/24HR TRANSDERMAL EMSAM PATCH 24 HOUR 6 MG/24HR TRANSDERMAL EMSAM PATCH 24 HOUR 9 MG/24HR TRANSDERMAL FETZIMA CAPSULE EXTENDED RELEASE 24 HOUR 120 MG ORAL FETZIMA

More information

ANTIDEPRESSANTS. Details. Step Therapy 2017 Last Updated: 5/23/2017

ANTIDEPRESSANTS. Details. Step Therapy 2017 Last Updated: 5/23/2017 ANTIDEPRESSANTS EMSAM PATCH 24 HOUR 12 MG/24HR TRANSDERMAL EMSAM PATCH 24 HOUR 6 MG/24HR TRANSDERMAL EMSAM PATCH 24 HOUR 9 MG/24HR TRANSDERMAL FETZIMA CAPSULE EXTENDED RELEASE 24 HOUR 120 MG FETZIMA CAPSULE

More information

U T I L I Z A T I O N E D I T S

U T I L I Z A T I O N E D I T S I N D I A N A H E A L T H C O V E R A G E P R O G R A M S U T I L I Z A T I O N E D I T S A P R I L 1 9, 2 0 1 2 s for s Refer to Provider Bulletin BT200709 for additional information regarding the Mental

More information

Texas Prior Authorization Program Clinical Edit Criteria

Texas Prior Authorization Program Clinical Edit Criteria Texas Prior Authorization Program Clinical Edit Criteria Drug/Drug Class Clinical Edit Information Included in this Document Drugs requiring prior authorization: the list of drugs requiring prior authorization

More information

Antipsychotics Prior Authorization Criteria for Louisiana Fee for Service and MCO Medicaid Recipients

Antipsychotics Prior Authorization Criteria for Louisiana Fee for Service and MCO Medicaid Recipients Antipsychotics Prior Authorization Criteria for Louisiana Fee for Service and MCO Medicaid Recipients Preferred Agents (Oral) a Amitriptyline/Perphenazine (Generic) Aripiprazole Tablet (Generic) b Chlorpromazine

More information

Drugs requiring prior authorization: the list of drugs requiring prior authorization for this clinical criteria

Drugs requiring prior authorization: the list of drugs requiring prior authorization for this clinical criteria Drug/Drug Class Antipsychotics Clinical Criteria Information Included in this Document Drugs requiring prior authorization: the list of drugs requiring prior authorization for this clinical criteria Prior

More information

Step Therapy Medications

Step Therapy Medications Step Therapy Medications Step Therapy Group APTIOM Step-2: APTIOM 200 MG TABLET or APTIOM 400 MG TABLET or APTIOM 600 MG TABLET or APTIOM 800 MG TABLET Step 1 Drug(s): Oxcarbazepine immediate-release,

More information

FirstCarolinaCare Insurance Company. Step Therapy Requirements

FirstCarolinaCare Insurance Company. Step Therapy Requirements FirstCarolinaCare Insurance Company Step Therapy Requirements Effective: 12/01/2018 ANTICONVULSANTS APTIOM 200 MG APTIOM 400 MG APTIOM 600 MG APTIOM 800 MG BANZEL 200 MG BANZEL 40 MG/ML ORAL SUSPENSION

More information

ANTICONVULSANTS. Details

ANTICONVULSANTS. Details ANTICONVULSANTS APTIOM 200 MG TABLET APTIOM 400 MG TABLET APTIOM 600 MG TABLET APTIOM 800 MG TABLET BANZEL 200 MG TABLET BANZEL 40 MG/ML ORAL SUSPENSION BANZEL 400 MG TABLET FYCOMPA 0.5 MG/ML ORAL SUSPENSION

More information

Santa Clara Family Health Plan Cal MediConnect Formulary. List of Step Therapy Requirements Effective: 12/01/ E

Santa Clara Family Health Plan Cal MediConnect Formulary. List of Step Therapy Requirements Effective: 12/01/ E Santa Clara Family Health Plan Cal MediConnect Formulary List of Step Therapy Requirements Effective: 12/01/2018 13027.12E ANTICONVULSANTS APTIOM 200 MG TABLET APTIOM 400 MG TABLET APTIOM 600 MG TABLET

More information

ANTICONVULSANTS. Details

ANTICONVULSANTS. Details ANTICONVULSANTS Aptiom 200 mg tablet Aptiom 400 mg tablet Aptiom 600 mg tablet Aptiom 800 mg tablet Banzel 200 mg tablet Banzel 40 mg/ml oral suspension Banzel 400 mg tablet Fycompa 0.5 mg/ml oral suspension

More information

ARISTADA. Products Affected Step 2: ARISTADA PREFILLED SYRINGE 1064 MG/3.9ML INTRAMUSCULAR ARISTADA PREFILLED SYRINGE 441 MG/1.

ARISTADA. Products Affected Step 2: ARISTADA PREFILLED SYRINGE 1064 MG/3.9ML INTRAMUSCULAR ARISTADA PREFILLED SYRINGE 441 MG/1. ARISTADA ARISTADA PREFILLED SYRINGE 1064 MG/3.9ML INTRAMUSCULAR ARISTADA PREFILLED SYRINGE 441 MG/1.6ML INTRAMUSCULAR ARISTADA PREFILLED SYRINGE 662 MG/2.4ML INTRAMUSCULAR ARISTADA PREFILLED SYRINGE 882

More information

Step Therapy Group. Atypical Antipsychotic Agents

Step Therapy Group. Atypical Antipsychotic Agents Atypical Antipsychotic Agents Any beneficiary newly enrolled into Community Care, Inc. currently receiving aripiprazole, aripiprazole ODT, risperidone, risperidone ODT, olanzapine, olanzapine ODT, quetiapine,

More information

Judges Reference Table for the March 2016 Psychotropic Medication Utilization Parameters for Foster Children

Judges Reference Table for the March 2016 Psychotropic Medication Utilization Parameters for Foster Children Judges Reference Table for the Psychotropic Medication Utilization Parameters for Foster Children Stimulants for treatment of ADHD Preschool (Ages 3-5 years) Child (Ages 6-12 years) Adolescent (Ages 13-17

More information

AMANTADINE ER. Products Affected Step 2: OSMOLEX ER 129 MG TABLET, EXTENDED RELEASE OSMOLEX ER 193 MG TABLET, Details

AMANTADINE ER. Products Affected Step 2: OSMOLEX ER 129 MG TABLET, EXTENDED RELEASE OSMOLEX ER 193 MG TABLET, Details AMANTADINE ER OSMOLEX ER 129 MG, EXTENDED RELEASE OSMOLEX ER 193 MG, EXTENDED RELEASE OSMOLEX ER 258 MG, EXTENDED RELEASE PRIOR CLAIM FOR AMANTADINE HCL IMMEDIATE RELEASE WITHIN THE PAST 120 DAYS. 1 ANTICONVULSANTS

More information

Step Therapy Requirements

Step Therapy Requirements Step Therapy Requirements Denver Health Medicare Choice (HMO SNP)/Medicare Select (HMO) Effective: 09/01/2017 Updated 08/2017 ANTICONVULSANTS Aptiom 200 mg tablet Aptiom 400 mg tablet Aptiom 600 mg tablet

More information

ANTICONVULSANTS. Details

ANTICONVULSANTS. Details ANTICONVULSANTS Aptiom 200 mg tablet Aptiom 400 mg tablet Aptiom 600 mg tablet Aptiom 800 mg tablet Banzel 200 mg tablet Banzel 40 mg/ml oral suspension Banzel 400 mg tablet Fycompa 0.5 mg/ml oral suspension

More information

Ohana Community Care Services (CCS) Comprehensive Preferred Drug List (List of Covered Drugs)

Ohana Community Care Services (CCS) Comprehensive Preferred Drug List (List of Covered Drugs) 2015 Ohana Community Care Services (CCS) Comprehensive referred Drug List (List of Covered Drugs) Ohana Health lan 00 lease read: This document contains information about the drugs we cover in this plan.

More information

ANTICONVULSANTS. Details

ANTICONVULSANTS. Details ANTICONVULSANTS APTIOM 200 MG APTIOM 400 MG APTIOM 600 MG APTIOM 800 MG BANZEL 200 MG BANZEL 40 MG/ML ORAL SUSPENSION BANZEL 400 MG FYCOMPA 0.5 MG/ML ORAL SUSPENSION FYCOMPA 10 MG FYCOMPA 12 MG FYCOMPA

More information

VNSNY CHOICE FIDA Complete Step Therapy Requirements. Effective: 01/01/2017

VNSNY CHOICE FIDA Complete Step Therapy Requirements. Effective: 01/01/2017 VNSNY CHOICE FIDA Complete Step Therapy Requirements Effective: 01/01/2017 Updated 12/23/2016 ANTICONVULSANTS Aptiom 200 mg tablet Potiga 200 mg tablet Aptiom 400 mg tablet Potiga 300 mg tablet Aptiom

More information

Medications and Children Disorders

Medications and Children Disorders Mental Health Comprehensive Services Providing Family Stability and Developing Life Coping Skills Medications and Children Disorders Psychiatric medications can be an effective part of the treatment for

More information

2015 Step Therapy Prior Authorization Medical Necessity Guidelines

2015 Step Therapy Prior Authorization Medical Necessity Guidelines Tufts Health Unify 2015 Step Therapy Prior Authorization Medical Necessity Guidelines Effective: 01/01/2015 Updated: 10/01/2015 Tufts Health Plan P.O. Box 9194 Watertown, MA 02471-9194 Phone: 855-393-3154

More information

ALAMEDA COUNTY BEHAVIORAL HEALTH CARE SERVICES MEDICATION FORMULARY

ALAMEDA COUNTY BEHAVIORAL HEALTH CARE SERVICES MEDICATION FORMULARY ANTIDEPRESSANTS Serotonin Selective Reuptake Inhibitors citalopram 10, 20, 40 mg, 10 mg/5cc $ 0.40 No escitalopram 10, 20 mg $ 2.60 Yes fluoxetine 10, 20 mg, 20 mg/5 ml $ 0.40 Yes fluvoxamine 25, 50, 100

More information

Pharmacy Benefit Management (PBM) Program FORMULARY/PRODUCT RESTRICTIONS

Pharmacy Benefit Management (PBM) Program FORMULARY/PRODUCT RESTRICTIONS Workforce Safety & Insurance Revised Document Date: 07/21/2015 1600 E Century Ave Ste 1 PO Box 5585 Bismarck, ND 58506-5585 701.328.3800 1.800.777.5033 www.workforcesafety.com Pharmacy Benefit Management

More information

A Brief Overview of Psychiatric Pharmacotherapy. Joel V. Oberstar, M.D. Chief Executive Officer

A Brief Overview of Psychiatric Pharmacotherapy. Joel V. Oberstar, M.D. Chief Executive Officer A Brief Overview of Psychiatric Pharmacotherapy Joel V. Oberstar, M.D. Chief Executive Officer Disclosures Some medications discussed are not approved by the FDA for use in the population discussed/described.

More information

Granite Alliance Insurance Company (PDP) 2018 Step Therapy Criteria Last Updated: 10/23/18

Granite Alliance Insurance Company (PDP) 2018 Step Therapy Criteria Last Updated: 10/23/18 Granite Alliance Insurance Company (PDP) 2018 Step Therapy Criteria Last Updated: 10/23/18 Granite Alliance requires step therapy for certain drugs. This means prior to receiving a drug with a step therapy

More information

IMPORTANT NOTICE. Changes to dispensing of some Behavioral Health Medications for DC Healthcare Alliance members

IMPORTANT NOTICE. Changes to dispensing of some Behavioral Health Medications for DC Healthcare Alliance members IMPORTANT NOTICE Changes to dispensing of some Behavioral Health Medications for DC Healthcare Alliance members These changes apply only to members covered under the DC Healthcare Alliance program Alliance

More information

CRITERIA Trial of two generic formulary products from the following: atomoxetine or ADHD stimulant medication.

CRITERIA Trial of two generic formulary products from the following: atomoxetine or ADHD stimulant medication. ADHD STIMULANTS ATOMOXETINE HCL, DEXEDRINE 10 MG TABLET, DEXEDRINE 5 MG TABLET, DEXMETHYLPHENIDATE HCL, DEXMETHYLPHENIDATE HCL ER, DEXTROAMPHETAMINE 10 MG TAB, DEXTROAMPHETAMINE 5 MG TAB, DEXTROAMPHETAMINE

More information

AMANTADINE ER. Products Affected Step 2: OSMOLEX ER 129 MG TABLET, EXTENDED RELEASE OSMOLEX ER 193 MG TABLET, Details

AMANTADINE ER. Products Affected Step 2: OSMOLEX ER 129 MG TABLET, EXTENDED RELEASE OSMOLEX ER 193 MG TABLET, Details AMANTADINE ER OSMOLEX ER 129 MG TABLET, EXTENDED RELEASE OSMOLEX ER 193 MG TABLET, EXTENDED RELEASE OSMOLEX ER 258 MG TABLET, PRIOR CLAIM FOR AMANTADINE HCL IMMEDIATE RELEASE WITHIN THE PAST 120 DAYS.

More information

Appendix: Psychotropic Medication Reference Tables

Appendix: Psychotropic Medication Reference Tables Appendix: Psychotropic Medication Reference Tables How to Use these Tables These reference tables are designed to provide clinic staff with specific medication related criteria for the Polypharmacy, Cardiometabolic

More information

VNSNY CHOICE FIDA Complete Step Therapy Requirements. Effective: 01/01/2017

VNSNY CHOICE FIDA Complete Step Therapy Requirements. Effective: 01/01/2017 Effective: 01/01/2017 Updated 11/2016 ANTI-INFLAMMATORY AGENTS - GI DIPENTUM PRIOR CLAIM FOR BALSALAZIDE OR APRISO WITHIN THE PAST 120 DAYS. ANTICONVULSANTS APTIOM BANZEL FYCOMPA GABITRIL OXTELLAR XR POTIGA

More information

Attention: Behavioral Health Providers, Pharmacists and Prescribers N.C. Medicaid and N.C. Health Choice Preferred Drug List Changes - UPDATE

Attention: Behavioral Health Providers, Pharmacists and Prescribers N.C. Medicaid and N.C. Health Choice Preferred Drug List Changes - UPDATE Attention: Behavioral Health Providers, Pharmacists and Prescribers N.C. Medicaid and N.C. Health Choice Drug List Changes - UPDATE Note: This article was previously published in the December 2014 Medicaid

More information

Step Therapy Requirements. Effective: 1/1/2019

Step Therapy Requirements. Effective: 1/1/2019 Effective: 1/1/2019 Updated 1/2019 AMANTADINE ER Sharp Health Plan (HMO) OSMOLEX ER 129 MG, EXTENDED RELEASE OSMOLEX ER 193 MG, EXTENDED RELEASE OSMOLEX ER 258 MG, EXTENDED RELEASE PRIOR CLAIM FOR AMANTADINE

More information

DIFICID. Products Affected Step 2: DIFICID TABLET 200 MG ORAL. Details

DIFICID. Products Affected Step 2: DIFICID TABLET 200 MG ORAL. Details DIFICID DIFICID TABLET 200 MG ORAL Claim will pay automatically for Dificid if enrollee has a paid claim for at least a 1 days supply of vancomycin in the past. Otherwise, Dificid requires a step therapy

More information

Step Therapy Requirements. Effective: 03/01/2015

Step Therapy Requirements. Effective: 03/01/2015 Effective: 03/01/2015 Updated 02/2015 ANTI-INFLAMMATORY AGENTS - GI DIPENTUM PRIOR CLAIM FOR BALSALAZIDE OR APRISO WITHIN THE PAST 120 DAYS. ANTICONVULSANTS APTIOM BANZEL FYCOMPA OXTELLAR XR POTIGA QUDEXY

More information

VNSNY CHOICE FIDA Complete Step Therapy Requirements. Effective: 04/01/2019

VNSNY CHOICE FIDA Complete Step Therapy Requirements. Effective: 04/01/2019 VNSNY CHOICE FIDA Complete Step Therapy Requirements Effective: 04/01/2019 Updated 03/2019 AMANTADINE ER OSMOLEX ER 129 MG, EXTENDED RELEASE OSMOLEX ER 193 MG, EXTENDED RELEASE OSMOLEX ER 258 MG, EXTENDED

More information

Antipsychotic Medications Age and Step Therapy

Antipsychotic Medications Age and Step Therapy Market DC *- Florida Healthy Kids Antipsychotic Medications Age and Step Therapy Override(s) Approval Duration Prior Authorization 1 year Quantity Limit *Virginia Medicaid See State Specific Mandates *Indiana

More information

AMANTADINE ER. Products Affected Step 2: OSMOLEX ER 129 MG TABLET, EXTENDED RELEASE OSMOLEX ER 193 MG TABLET, Details

AMANTADINE ER. Products Affected Step 2: OSMOLEX ER 129 MG TABLET, EXTENDED RELEASE OSMOLEX ER 193 MG TABLET, Details AMANTADINE ER OSMOLEX ER 129 MG TABLET, EXTENDED RELEASE OSMOLEX ER 193 MG TABLET, EXTENDED RELEASE OSMOLEX ER 258 MG TABLET, PRIOR CLAIM FOR AMANTADINE HCL IMMEDIATE RELEASE WITHIN THE PAST 120 DAYS.

More information

Simply Step Therapy Document September 2018 Y0114_18_33074_I_009

Simply Step Therapy Document September 2018 Y0114_18_33074_I_009 2018 2018 Simply Step Therapy Document September 2018 Aptiom APTIOM 200 MG TABLET APTIOM 400 MG TABLET Y0114_18_33074_I_009 APTIOM 600 MG TABLET APTIOM 800 MG TABLET Criteria If the patient has tried a

More information

ANTIDEPRESSANTS. Details. dose pack Viibryd 10 mg tablet Viibryd 20 mg tablet Viibryd 40 mg tablet. Criteria

ANTIDEPRESSANTS. Details. dose pack Viibryd 10 mg tablet Viibryd 20 mg tablet Viibryd 40 mg tablet. Criteria ANTIDEPRESSANTS Trintellix 10 mg tablet Trintellix 20 mg tablet Trintellix 5 mg tablet Viibryd 10 mg (7)-20 mg (23) tablets in a dose pack Viibryd 10 mg tablet Viibryd 20 mg tablet Viibryd 40 mg tablet

More information

Step Therapy Requirements. Effective: 11/01/2018

Step Therapy Requirements. Effective: 11/01/2018 Effective: 11/01/2018 Updated 10/2018 ANTIDEPRESSANTS Sharp Health Plan (HMO) TRINTELLIX 10 MG TABLET TRINTELLIX 20 MG TABLET TRINTELLIX 5 MG TABLET VIIBRYD 10 MG (7)-20 MG (23) TABLETS IN A DOSE PACK

More information

Pharmacy Medical Necessity Guidelines: Antipsychotic Medications

Pharmacy Medical Necessity Guidelines: Antipsychotic Medications Pharmacy Medical Necessity Guidelines: Effective: October 1, 2016 Prior Authorization Required Type of Review Care Management Not Covered Type of Review Clinical Review Pharmacy (RX) or Medical (MED) Benefit

More information

Step Therapy Requirements. Effective: 05/01/2018

Step Therapy Requirements. Effective: 05/01/2018 Step Therapy Requirements Effective: 05/01/2018 ANTIDEPRESSANTS TRINTELLIX 10 MG TABLET TRINTELLIX 20 MG TABLET TRINTELLIX 5 MG TABLET VIIBRYD 10 MG (7)-20 MG (23) TABLETS IN A DOSE PACK VIIBRYD 10 MG

More information

CENPATICO INTEGRATED CARE BEHAVIORAL HEALTH DRUG LIST BY DRUG NAME. Use Brand Only

CENPATICO INTEGRATED CARE BEHAVIORAL HEALTH DRUG LIST BY DRUG NAME. Use Brand Only ACAMPROSATE TABLET DELAYED RELEASE ALPHA-TOCOPHEROL CAPSULES ALPRAZOLAM CONCENTRATE 1 MG/ML ALPRAZOLAM ODT TABLET 0.25MG, 0.5MG, 1MG ALPRAZOLAM ODT TABLET 2MG ALPRAZOLAM SR TABLET 24-HOUR ALPRAZOLAM TABLET

More information

Harvard Pilgrim Health Care Stride SM Basic Rx (HMO), Stride SM Value Rx (HMO), Stride SM Value Rx Plus (HMO) and Stride SM Gain Rx (HMO)

Harvard Pilgrim Health Care Stride SM Basic Rx (HMO), Stride SM Value Rx (HMO), Stride SM Value Rx Plus (HMO) and Stride SM Gain Rx (HMO) Harvard Pilgrim Health Care Stride SM Basic Rx (HMO), Stride SM Value Rx (HMO), Stride SM Value Rx Plus (HMO) and Stride SM Gain Rx (HMO) Step Therapy Requirements Effective 4/1/2019 Updated 3/2019 BRAND

More information

2019 PDP Basic Step Therapy Document

2019 PDP Basic Step Therapy Document Aggrenox 2019 PDP Basic Step Therapy Document AGGRENOX 25 MG-200 MG CAPSULE, EXTENDED aspirin 25 mg-dipyridamole 200 mg capsule,ext.release 12 hr multiphase drug may be given. Step 1 Drug(s): clopidigrel.

More information

Pharmacy Medical Necessity Guidelines: Antipsychotic Medications

Pharmacy Medical Necessity Guidelines: Antipsychotic Medications Pharmacy Medical Necessity Guidelines: Effective: April 1, 2018 Prior Authorization Required Type of Review Care Management Not Covered Type of Review Clinical Review Pharmacy (RX) or Medical (MED) Benefit

More information

MO Medicaid Foster Care Drugs FY10-FY14

MO Medicaid Foster Care Drugs FY10-FY14 MO Medicaid Foster Care Drugs FY10-FY14 Medicaid (MO HealthNet) Cost of Drugs given to Missouri Foster Care Children by combinations of Age, Gender, Drug Class and Fiscal Year [Raw Data Provided by Missouri

More information

NorthSTAR. Pharmacy Manual

NorthSTAR. Pharmacy Manual NorthSTAR Pharmacy Manual Revised October, 2008 Table of I. Introduction II. III. IV. Antidepressants New Generation Antipsychotic Medications Mood Stabilizers V. ADHD Medications VI. Anxiolytics and Sedative-Hypnotics

More information

ADHD STIMULANTS-S(SHC)

ADHD STIMULANTS-S(SHC) Step Therapy Simply Health Care 2014 Formulary ID: 14406 Version: 14 Last Updated: 08/01/2014 ADHD STIMULANTS-S(SHC) Daytrana Focalin Xr Strattera Patient needs to have a paid claim for one Step 1 drug

More information

CARE N CARE HEALTH PLAN

CARE N CARE HEALTH PLAN PPI DEXILANT CAPSULE DELAYED RELEASE 30 MG ORAL DEXILANT CAPSULE DELAYED RELEASE 60 MG ORAL Claim will pay automatically for Dexilant if enrollee has a paid claim for at least a 1 days supply of lansoprazole,

More information

ALLERGIC CONJUNCTIVITIS AGENTS

ALLERGIC CONJUNCTIVITIS AGENTS 2018 5 Tier Standard- Keystone First VIP Choice Document: 2018 Step Therapy Formulary ID: 18390 Last Updated: 04/2018 Effective Date: 05-01-2018 ALLERGIC CONJUNCTIVITIS AGENTS epinastine 0.05 % eye drops

More information

CONTRAINDICATIONS TABLE

CONTRAINDICATIONS TABLE CONTRAINDICATIONS TABLE Generic Name Brand Name Contraindications Amphetamine Salts Adderall, Adderall XR Hypersensitivity to amphetamine, dextroamphetamine, or other sympathomimetic amines Advanced arteriosclerosis

More information

ANGIOTENSIN RECEPTOR BLOCKERS STEP THERAPY

ANGIOTENSIN RECEPTOR BLOCKERS STEP THERAPY South Country Health Alliance 2017 Step Therapy Formulary ID: 17431 Last Updated: 10/20/2017 Effective Date: 11-01-2017 ANGIOTENSIN RECEPTOR BLOCKERS STEP THERAPY BENICAR 20 MG BENICAR 40 MG BENICAR 5

More information

Relative Cost/Month. Less than $10. Loratadine Liquid* $10-$15 Cetirizine liquid 1mg/mL*

Relative Cost/Month. Less than $10. Loratadine Liquid* $10-$15 Cetirizine liquid 1mg/mL* Allergy Chlorpheniramine Tablet* Diphenhydramine Tablet* Diphenhydramine Liquid* Loratadine Tablet* Cetirizine Tablet* Loratadine 10mg ODT* Less than $10 Loratadine Liquid* $10-$15 Cetirizine liquid 1mg/mL*

More information

2019 Simply Step Therapy Document

2019 Simply Step Therapy Document Aggrenox 2019 Simply Step Therapy Document AGGRENOX 25 MG-200 MG CAPSULE, EXTENDED aspirin 25 mg-dipyridamole 200 mg capsule,ext.release 12 hr multiphase drug may be given. Step 1 Drug(s): clopidigrel.

More information

2017 Step Therapy Criteria

2017 Step Therapy Criteria FRESENIUS TOTAL HEALTH 2017 Step Therapy Updated 07/01/2017. For more recent information or other questions, please contact Fresenius Total Health Customer Service at 1-855-598-6774 / TTY 1-844-209-9094.

More information

ANTIDIABETIC AGENTS - MISCELLANEOUS

ANTIDIABETIC AGENTS - MISCELLANEOUS ANTIDIABETIC AGENTS - MISCELLANEOUS Glyxambi 10 mg-5 mg tablet Glyxambi 25 mg-5 mg tablet Invokamet 150 mg-1,000 mg tablet Invokamet 150 mg-500 mg tablet Invokamet 50 mg-1,000 mg tablet Invokamet 50 mg-500

More information

PPHP 2017 Formulary 2017 Step Therapy Criteria

PPHP 2017 Formulary 2017 Step Therapy Criteria ARISTADA Aristada Prefilled Syringe 1064 MG/3.9ML Intramuscular Aristada Prefilled Syringe 441 MG/1.6ML Intramuscular Aristada Prefilled Syringe 662 MG/2.4ML Intramuscular Aristada Prefilled Syringe 882

More information

ANTIDIABETIC AGENTS - MISCELLANEOUS

ANTIDIABETIC AGENTS - MISCELLANEOUS ANTIDIABETIC AGENTS - MISCELLANEOUS Glyxambi 10 mg-5 mg tablet Glyxambi 25 mg-5 mg tablet Invokamet 150 mg-1,000 mg tablet Invokamet 150 mg-500 mg tablet Invokamet 50 mg-1,000 mg tablet Invokamet 50 mg-500

More information

Harvard Pilgrim Health Care Stride SM Basic Rx (HMO), Stride SM Value Rx (HMO) and Stride SM Value Rx Plus (HMO) Step Therapy Requirements

Harvard Pilgrim Health Care Stride SM Basic Rx (HMO), Stride SM Value Rx (HMO) and Stride SM Value Rx Plus (HMO) Step Therapy Requirements Harvard Pilgrim Health Care Stride SM Basic Rx (HMO), Stride SM Value Rx (HMO) and Stride SM Value Rx Plus (HMO) Step Therapy Requirements Effective 7/1/2018 Updated 6/2018 BRAND NAME ANTIDEPRESSANTS APLENZIN

More information

ANTIDIABETIC AGENTS - MISCELLANEOUS

ANTIDIABETIC AGENTS - MISCELLANEOUS ANTIDIABETIC AGENTS - MISCELLANEOUS GLYXAMBI 10 MG-5 MG GLYXAMBI 25 MG-5 MG INVOKAMET 150 MG-1,000 MG INVOKAMET 150 MG-500 MG INVOKAMET 50 MG-1,000 MG INVOKAMET 50 MG-500 MG INVOKAMET XR 150 MG-1,000 MG,

More information

Review of Psychotrophic Medications. (An approved North Carolina Division of Health Services Regulation Continuing Education Course)

Review of Psychotrophic Medications. (An approved North Carolina Division of Health Services Regulation Continuing Education Course) Review of Psychotrophic Medications (An approved North Carolina Division of Health Services Regulation Continuing Education Course) Common Psychiatric Disorders *Schizophrenia *Depression *Bipolar Disorder

More information

CARE N CARE HEALTH PLAN

CARE N CARE HEALTH PLAN ARISTADA Aristada Prefilled Syringe 441 MG/1.6ML Intramuscular Aristada Prefilled Syringe 662 MG/2.4ML Intramuscular Aristada Prefilled Syringe 882 MG/3.2ML Intramuscular Claim will pay automatically for

More information

CARE N CARE HEALTH PLAN

CARE N CARE HEALTH PLAN ARISTADA ARISTADA PREFILLED SYRINGE 1064 MG/3.9ML INTRAMUSCULAR ARISTADA PREFILLED SYRINGE 441 MG/1.6ML INTRAMUSCULAR ARISTADA PREFILLED SYRINGE 662 MG/2.4ML INTRAMUSCULAR ARISTADA PREFILLED SYRINGE 882

More information

HEALTHTEAM ADVANTAGE 2018 Step Therapy Criteria

HEALTHTEAM ADVANTAGE 2018 Step Therapy Criteria GLP1-INSULIN XULTOPHY SOLUTION PEN- INJECTOR 100-3.6 UNIT-MG/ML Claim will pay automatically for Xultophy if enrollee has a paid claim for at least a one day supply for step level 1 agent (LANTUS, LEVEMIR,

More information

AHCCCS BEHAVIORAL HEALTH DRUG LIST EFFECTIVE OCTOBER 1, 2016

AHCCCS BEHAVIORAL HEALTH DRUG LIST EFFECTIVE OCTOBER 1, 2016 Generic Drugs Are Preferred Over Brand Name Drugs Unless Specified As Brand Only Federally Reimbursable Drugs Not Listed On The AHCCCS Drug List Are Available Through Prior Authorization Effective Date

More information

HEALTHTEAM ADVANTAGE 2018 Step Therapy Criteria

HEALTHTEAM ADVANTAGE 2018 Step Therapy Criteria GLP1-INSULIN XULTOPHY SOLUTION PEN- INJECTOR 100-3.6 UNIT-MG/ML HEALTHTEAM ADVANTAGE Claim will pay automatically for Xultophy if enrollee has a paid claim for at least a one day supply for step level

More information

2018 PDP Premier Step Therapy Document September 2018 Y0114_18_33144_I_009

2018 PDP Premier Step Therapy Document September 2018 Y0114_18_33144_I_009 2018 PDP Premier Step Therapy Document September 2018 Aggrenox Y0114_18_33144_I_009 aspirin 25 mg-dipyridamole 200 mg capsule,ext.release 12 hr multiphase drug may be given. Step 1 Drug(s): clopidigrel.

More information

Commissioner for the Department for Medicaid Services Selections for Preferred Products

Commissioner for the Department for Medicaid Services Selections for Preferred Products Commissioner for the Department for Medicaid Services Selections for Preferred Products This is a summary of the final Preferred Drug List (PDL) selections made by the Commissioner for the Department for

More information

HOSPITAL BASED INPATIENT PSYCHIATRIC SERVICES (HBIPS) MEASURE SET

HOSPITAL BASED INPATIENT PSYCHIATRIC SERVICES (HBIPS) MEASURE SET HOSPITAL BASED INPATIENT PSYCHIATRIC SERVICES (HBIPS) MEASURE SET Kathy Wonderly RN, MSEd, CPHQ Consultant Developed: February, 2013 Most recently revised: December 2018 The Psychiatric Measure Set CMS

More information

ALPHA GLUCOSIDASE INHIBITOR THERAPY

ALPHA GLUCOSIDASE INHIBITOR THERAPY ALPHA GLUCOSIDASE INHIBITOR THERAPY GLYSET Step 1: One generic formulary product containing one of the following ingredients: glimeperide, glipizide, metformin or pioglitazone. Step 2: Glyset PAGE 1 LAST

More information

Use Brand Only. Preferred Drug Status PRIOR AUTHORIZATION REQUIRED

Use Brand Only. Preferred Drug Status PRIOR AUTHORIZATION REQUIRED Generic Drugs Are Over Brand Drugs Unless Specified As Brand ANTIDEPRESSANTS ALPHA-2 RECEPTOR ANTAGONIST ANTIDEPRESSANTS MIRTAZAPINE REMERON 30 30 MIRTAZAPINE REMERON SOLTAB 30 30 ISOCARBOXAZID TABLETS

More information

Dealing with a Mental Health Crisis

Dealing with a Mental Health Crisis Dealing with a Mental Health Crisis Information and Resources for First Responders P... PROFESSIONAL WHAT NAMI DOES NAMI Minnesota is a statewide 501(c)(3) grassroots nonprofit organization dedicated to

More information

HEDIS BEHAVIORAL HEALTH RESOURCE GUIDE

HEDIS BEHAVIORAL HEALTH RESOURCE GUIDE HEDIS BEHAVIORAL HEALTH RESOURCE GUIDE What is HEDIS? 3 HEDIS Reference Guide for Behavioral Health 4 Behavioral Health HEDIS Measures 13 WHAT IS HEDIS? HEDIS (Healthcare Effectiveness Data and Information

More information

WELLCARE/ OHANA HEALTH PLAN 2015 STEP THERAPY CRITERIA (No Changes Made Since: 08/2015)

WELLCARE/ OHANA HEALTH PLAN 2015 STEP THERAPY CRITERIA (No Changes Made Since: 08/2015) WELLCARE/ OHANA HEALTH PLAN 2015 STEP THERAPY CRITERIA (No Changes Made Since: 08/2015) **To get updated information about the drugs covered by WellCare/ Ohana, please visit our website (https://www.wellcare.com

More information

Psychotropic Medications Archana Jhawar, PharmD, BCPP Clinical Faculty of UIC Pharmacy Practice Clinical Psychiatric Pharmacist Jesse Brown VA

Psychotropic Medications Archana Jhawar, PharmD, BCPP Clinical Faculty of UIC Pharmacy Practice Clinical Psychiatric Pharmacist Jesse Brown VA Psychotropic Medications Archana Jhawar, PharmD, BCPP Clinical Faculty of UIC Pharmacy Practice Clinical Psychiatric Pharmacist Jesse Brown VA Goals of Medications Use least number at lowest dose to get

More information

Schedule FDA & literature based indications

Schedule FDA & literature based indications Psychotropic Medication List Recommended dosages are intended to serve only as a guide for children. Recommended doses are literature based. Clinicians should consult package insert of medications for

More information

Pharmacy Medical Necessity Guidelines: Antipsychotic Medications

Pharmacy Medical Necessity Guidelines: Antipsychotic Medications Pharmacy Medical Necessity Guidelines: Antipsychotic Medications Effective: July. 1, 2016 Prior Authorization Required Type of Review Care Management Not Covered Type of Review Clinical Review Pharmacy

More information

See Important Reminder at the end of this policy for important regulatory and legal information.

See Important Reminder at the end of this policy for important regulatory and legal information. Clinical Policy: (Invega Sustenna, Invega Trinza) Reference Number: CP.PHAR.291 Effective Date: 12.01.16 Last Review Date: 08.18 Line of Business: Medicaid See Important Reminder at the end of this policy

More information

2018 Step Therapy Criteria

2018 Step Therapy Criteria 2018 Step Therapy Criteria ANGIOTENSIN RECEPTOR BLOCKERS... 2 ANTIDEPRESSANTS... 3 ANTIDEPRESSANTS, MISCELLANEOUS... 4 ANTIDEPRESSANTS, OTHER... 5 ANTIDIABETIC AGENTS... 6 ANTIGOUT AGENTS... 7 ANTIHYPERTENSIVE

More information

Nuplazid (pimavanserin)

Nuplazid (pimavanserin) Texas Prior Authorization Program Clinical Criteria Drug/Drug Class This criteria was recommended for review by the Texas Medicaid Vendor Drug Program to ensure appropriate and safe utilization. Additional

More information

Avoid paying too much for your prescriptions

Avoid paying too much for your prescriptions Quality health plans & benefits Healthier living Financial well-being Intelligent solutions 2017 Aetna Rx Step Program Medicine List Avoid paying too much for your prescriptions It s important to try to

More information

Rexulti (brexpiprazole)

Rexulti (brexpiprazole) Market DC Rexulti (brexpiprazole) Override(s) Approval Duration Prior Authorization 1 year Quantity Limit *Indiana see State Specific Mandates below *Maryland see State Specific Mandates below *Virginia

More information

Texas Standard Prior Authorization Form Addendum

Texas Standard Prior Authorization Form Addendum Texas Standard Prior Authorization Form Addendum Molina Healthcare of Texas Antipsychotics (Medicaid) This fax machine is located in a secure location as required by HIPAA Regulations. Complete / Review

More information

2018 STEP THERAPY CRITERIA UCare Connect (SNBC) MinnesotaCare Prepaid Medical Assistance Program (PMAP) Minnesota Senior Care Plus (MSC+)

2018 STEP THERAPY CRITERIA UCare Connect (SNBC) MinnesotaCare Prepaid Medical Assistance Program (PMAP) Minnesota Senior Care Plus (MSC+) 2018 STEP THERAPY CRITERIA UCare Connect (SNBC) MinnesotaCare Prepaid Medical Assistance Program (PMAP) Minnesota Senior Care Plus (MSC+) In some cases, UCare requires you to first try certain drugs to

More information

HCA BHS Prescribing Guidelines Committee - Approved Medications 2012

HCA BHS Prescribing Guidelines Committee - Approved Medications 2012 Amitriptyline/Perphenazine Triavil MAJOR TRANQUILIZERS Beneficiaries 10/2, 10/4, 25/2, 25/4, 50/4 Aripiprazole Abilify 2mg, 5mg, 10mg, 15mg, 20mg, 30mg Quantity Limit 31 / mo for Asenapine Saphris 5mg,

More information

Medicare Part D Drugs that Require Step Therapy Effective 12/01/2017

Medicare Part D Drugs that Require Step Therapy Effective 12/01/2017 Medicare Part D Drugs that Require Step Therapy Effective 12/01/2017 Providers may call the Pharmacy Help Desk at 800-641-8921 for more information or questions about criteria. The formulary may change

More information

USF Health Psychiatry Clinic. New Patient Questionnaire Adult

USF Health Psychiatry Clinic. New Patient Questionnaire Adult USF Health Psychiatry Clinic New Patient Questionnaire Adult Please mail or fax the completed forms to the address/fax number on the bottom of this page. Completed forms must be received five (5) days

More information